Isn’t it time for primary angioplasty in the UK?

September 2003    Volume 10, Issue 3   Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 66–AIC 70

Authors:
Elliot J Smith, Martin T Rothman

Thrombolytic therapy remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the UK, with government policy directed towards optimising thrombolytic delivery. However, the publication of the first Myocardial Infarction National Audit Project (MINAP) report last year informed us that only 28% of hospitals supplying data treated the target 75% of eligible patients inside 30 minutes.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top